Gland Pharma Limited — Important, 09-08-2026: Arrangements for strategic, technical, manufacturing, or marketing tie up

Gland Pharma partnered with a global pharma company for a full-service CDMO agreement to manufacture sterile injectable products. This collaboration covers 55 SKUs across three sites, with expected annual revenue potential of USD 90-100 million starting 2029, boosting long-term visibility.